Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9229 USD | -4.91% | -4.19% | -33.12% |
Mar. 27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
Mar. 27 | Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.12% | 178M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.31% | 22.2B | |
-16.53% | 21.23B | |
-8.75% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- bluebird bio : Barclays Adjusts bluebird bio PT to $27 From $31, Maintains Equal Weight Rating